182 related articles for article (PubMed ID: 31587105)
1. "Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation".
Wareham NE; Li Q; Sengeløv H; Da Cunha-Bang C; Gustafsson F; Heilmann C; Perch M; Rasmussen A; Sørensen SS; Mocroft A; Lundgren JD
J Cancer Res Clin Oncol; 2019 Dec; 145(12):3125-3135. PubMed ID: 31587105
[TBL] [Abstract][Full Text] [Related]
2. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y;
Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081
[TBL] [Abstract][Full Text] [Related]
3. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
4. Cancer incidence in immunocompromised patients: a single-center cohort study.
Ilham S; Willis C; Kim K; Chung KC; Wood BM; Tan MS; Tan CJ; Nguyen DT; Brixner DI; Stenehjem DD
BMC Cancer; 2023 Jan; 23(1):33. PubMed ID: 36624408
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.
Bhat M; Mara K; Dierkhising R; Watt KDS
Mayo Clin Proc; 2018 Sep; 93(9):1236-1246. PubMed ID: 30064826
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.
Tichelli A; Beohou E; Labopin M; Socié G; Rovó A; Badoglio M; van Biezen A; Bader P; Duarte RF; Basak G; Salooja N;
JAMA Oncol; 2019 Feb; 5(2):229-235. PubMed ID: 30476975
[TBL] [Abstract][Full Text] [Related]
7. Second neoplasms in adult patients submitted to haematopoietic stem cell transplantation.
Torrent A; Ferrá C; Morgades M; Jiménez MJ; Sancho JM; Vives S; Batlle M; Moreno M; Xicoy B; Oriol A; Ibarra G; Ribera JM
Med Clin (Barc); 2018 Jun; 150(11):421-427. PubMed ID: 28874263
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.
Neofytos D; Treadway S; Ostrander D; Alonso CD; Dierberg KL; Nussenblatt V; Durand CM; Thompson CB; Marr KA
Transpl Infect Dis; 2013 Jun; 15(3):233-42. PubMed ID: 23432974
[TBL] [Abstract][Full Text] [Related]
9. Risk of Subsequent Vitiligo in Transplant Recipients With Comorbid Graft-vs-Host Disease.
Bang CH; Park HE; Kim YH; Jung JH; Lee JH; Park YM; Han JH
JAMA Dermatol; 2024 Feb; 160(2):194-198. PubMed ID: 38091023
[TBL] [Abstract][Full Text] [Related]
10. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program.
Morgan J; Wannemuehler KA; Marr KA; Hadley S; Kontoyiannis DP; Walsh TJ; Fridkin SK; Pappas PG; Warnock DW
Med Mycol; 2005 May; 43 Suppl 1():S49-58. PubMed ID: 16110792
[TBL] [Abstract][Full Text] [Related]
11. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients.
Wareham NE; Mocroft A; Sengeløv H; Da Cunha-Bang C; Gustafsson F; Heilmann C; Iversen M; Kirkby NS; Rasmussen A; Sørensen SS; Lundgren JD;
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1569-1580. PubMed ID: 29804164
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of early vaccination with live attenuated measles vaccine for hematopoietic stem cell transplant recipients and solid organ transplant recipients.
Groeneweg L; Loeffen YGT; Versluys AB; Wolfs TFW
Vaccine; 2021 Jun; 39(25):3338-3345. PubMed ID: 33992440
[TBL] [Abstract][Full Text] [Related]
13. Orofacial diseases in solid organ and hematopoietic stem cell transplant recipients.
Petti S; Polimeni A; Berloco PB; Scully C
Oral Dis; 2013 Jan; 19(1):18-36. PubMed ID: 22458357
[TBL] [Abstract][Full Text] [Related]
14. De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study.
Tsai HI; Lee CW; Kuo CF; See LC; Liu FC; Chiou MJ; Yu HP
Oncotarget; 2017 May; 8(22):36685-36695. PubMed ID: 27821818
[TBL] [Abstract][Full Text] [Related]
15. De novo head and neck cancer arising in solid organ transplantation recipients: The Asan Medical Center experience.
Park MJ; Roh JL; Choi SH; Nam SY; Kim SY; Lee YS
Auris Nasus Larynx; 2018 Aug; 45(4):838-845. PubMed ID: 29150348
[TBL] [Abstract][Full Text] [Related]
16. Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study.
Fan WC; Liu CJ; Hong YC; Feng JY; Su WJ; Chien SH; Chen TJ; Chiang CH
Int J Tuberc Lung Dis; 2015 Jan; 19(1):58-64. PubMed ID: 25519791
[TBL] [Abstract][Full Text] [Related]
17. Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT.
Koenecke C; Hertenstein B; Schetelig J; van Biezen A; Dammann E; Gratwohl A; Ganser A; Schleuning M; Bornhäuser M; Jacobsen N; Kröger N; Niederwieser D; de Witte T; Ruutu T
Am J Transplant; 2010 Aug; 10(8):1897-906. PubMed ID: 20659095
[TBL] [Abstract][Full Text] [Related]
18. Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study.
Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Shen CC; Ku FC; Chen SC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
Br J Cancer; 2015 Jan; 112(1):177-84. PubMed ID: 25314066
[TBL] [Abstract][Full Text] [Related]
19. Secondary cancers following allogeneic haematopoietic cell transplantation in adults.
Majhail NS
Br J Haematol; 2011 Aug; 154(3):301-10. PubMed ID: 21615719
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants.
Panagou E; Zakout G; Keshani J; Smith C; Irish D; Mackinnon S; Kottaridis P; Fielding A; Griffiths PD
Transpl Infect Dis; 2016 Jun; 18(3):405-14. PubMed ID: 27061703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
